Skip to content

VCMX, PRF and SCTG Treatment in the Gingival Recessions

Comparison of Volume Stable Collagen Matrix, Platelet-Rich Fibrin and Connective Tissue Graft in the Treatment of Multiple Gingival Recessions: A Randomized, Parallel Group, Controlled Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07345520
Enrollment
60
Registered
2026-01-15
Start date
2022-12-01
Completion date
2024-10-01
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession, Localized

Brief summary

Comparison of Volume-Stable Collagen Matrix, Platelet-Rich Fibrin, and Subepithelial Connective Tissue Graft in the Treatment of Multiple Adjacent Gingival Recessions: A Parallel-Group, Randomized, Controlled Clinical Trial

Interventions

Volume-Stable Collagen Matrix

Sponsors

Bulent Ecevit University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

A Parallel-Group, Randomized, Controlled Clinical Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

were as follows: 1. ≥2 mm buccal recessions affecting ≥2 adjacent maxillary teeth; 2. systemically and periodontally healthy; 3. non-smokers; 4. Miller Class I-II (no interproximal attachment or CEJ loss); 5. probing depth (PD) \<3 mm; 6. GT ≥1 mm; 7. KGW ≥2 mm; 8. identifiable CEJ; 9. full-mouth plaque index (PI) \<20%(O'Leary et al., 1972) and gingival index (GI) score of 0(Löe, 1967) and 10. vital teeth to be treated.

Exclusion criteria

included: 1. smokers; 2. caries/restorations/abrasions in the treated area, furcation involvement; 3. contraindications to surgery; 4. pregnancy or lactation; 5. medications compromising healing; 6. surgery in the same region within 2 years; 7. bleeding disorders; 8. requirement for antibiotic prophylaxis; and 9. collagen allergy.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Complete Root Coverage12 MonthsPercentage of CRC will be calculated as: (number of teeth achieving complete root coverage) ÷ (total treated teeth)\] × 100

Secondary

MeasureTime frameDescription
Recession depth12 monthRD will be measured from the cemento-enamel junction (CEJ) to the gingival margin and reported in millimeters (mm).
Probing depth12 monthsProbing depth will be measured from the gingival margin to the base of the sulcus and reported in millimeters (mm).
Clinical attachment level12 monthsClinical attachment level will be measured from the cemento-enamel junction to the sulcus base and reported in millimeters (mm).
Keratinized gingiva width12 monthsKGW will be measured from the mucogingival junction to the gingival margin and reported in millimeters (mm).
Percentage of Mean Root Coverage12 monthsPercentage of root coverage will be calculated as: Percentage of root coverage: \[(preoperative recession depth - postoperative recession depth) ÷ preoperative recession depth\] × 100
Postoperative Pain assessed using a Visual Analog Scale (VAS)From the day of surgery through postoperative day 10 (11 days)Postoperative pain will be assessed using a visual analog scale (VAS). Patients were asked to record the highest perceived pain each day from the day of surgery through the 10th postoperative day (total of 11 days).
Dentin Hypersensitivity Score assessed using Air Stimulus (HSS)Baseline, 6 months, and 12 monthsDentin hypersensitivity will be assessed using a 1-second air stimulus applied to the buccal surface of the treated tooth. Patients rated the perceived hypersensitivity on a numerical rating scale ranging from 0 (no hypersensitivity) to 10 (unbearable hypersensitivity).
Pink Esthetic Score (PES) self-assessmentBaseline, 6 months, and 12 monthsEsthetic outcomes will be evaluated using the Pink Esthetic Score (PES). Patients self-assessed gingival contour, gingival color, and overall esthetic appearance using a numerical rating scale ranging from 0 (unpleasant) to 10 (excellent).
Postoperative Analgesic ConsumptionFrom the day of surgery through postoperative day 10 (11 days)Postoperative analgesic consumption will be assessed by recording the total number of analgesic tablets taken by patients from the day of surgery through the 10th postoperative day.
Gingival Thickness12 monthsGingival thickness (GT) will beevaluated at the mid-facial aspect, 2 mm apical to the gingival margin in the attached gingiva or alveolar mucosa, using a #15 endodontic spreader (Bahadır Diş, Istanbul, Turkey) with a rubber stopper under local anesthesia and reported in milimeters.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026